Beijing Scitop Bio-tech Co., Ltd. Stock: price and insider trades · China
科拓生物
Beijing Scitop Bio-tech Co., Ltd.: what insiders have been doing
This page follows insider dealings at Beijing Scitop Bio-tech Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. The last twelve months, up to 5 November 2026, brought 3 filings signed by 1 insider.
There is no open-market purchase to report; the filings show 3 sales worth €1.2M by 1 insider. The largest single trade was a sale of €673k by 乔向前, published on 11 December 2025.
Compared with its exchange (519 companies, median 2 filings), a count of 3 filings is above the norm. The full history, which starts in 2022, counts no purchases against 6 sales.
Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 332,800 shares56.7% of flowA股XSHESZSE:273000000019143740
- 60,000 shares10.4% of flowA股XSHESZSE:273000000016475070
- 159,500 shares32.9% of flowA股XSHESZSE:173000009784008030
- 28,700 shares25.5% of flowA股XSHESZSE:173000006322149400
- 63,200 shares56.6% of flowA股XSHESZSE:173000006306768500
- 22,200 shares17.9% of flowA股XSHESZSE:173000005369670080
6 of 6 declarations
About Beijing Scitop Bio-tech Co., Ltd.
科拓生物 is a company specializing in the health and pharmaceutical sector, focused on developing biopharmaceutical solutions. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
